(BBWI) Bath & Body Works - Overview
Stock: Candles, Lotions, Soaps, Sanitizers, Mists
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.26% |
| Yield on Cost 5y | 2.83% |
| Yield CAGR 5y | -54.94% |
| Payout Consistency | 82.0% |
| Payout Ratio | 24.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 47.1% |
| Relative Tail Risk | -8.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.54 |
| Alpha | -61.62 |
| Character TTM | |
|---|---|
| Beta | 1.641 |
| Beta Downside | 1.889 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.98% |
| CAGR/Max DD | -0.25 |
Description: BBWI Bath & Body Works January 09, 2026
Bath & Body Works, Inc. is a specialty retailer focused on home fragrance, personal care, soaps, and sanitizers, offering products such as 3-wick candles, diffusers, fine-fragrance mists, liquid hand soaps, body lotions, and creams.
The company markets its merchandise under the Bath & Body Works, White Barn, and other brand names through a network of over 1,800 retail stores and a growing e-commerce platform in the United States and Canada, while international exposure is provided via franchise, licensing, and wholesale partnerships.
Originally founded in 1963 and formerly known as L Brands, Inc., the firm rebranded to Bath & Body Works, Inc. in August 2021; its headquarters remain in Columbus, Ohio.
BBWI (NYSE) trades as a common stock in the “Other Specialty Retail” sub-industry. In FY 2023 the company generated roughly $3.5 billion in revenue, with comparable-store sales up 5.2% and e-commerce contributing about 30% of total sales-a trend driven by higher consumer spending on discretionary home-and-personal-care items and a resilient fragrance market that is expanding at ~5% CAGR. Operating margins hovered near 12%, reflecting efficient cost control amid modest inflationary pressure on raw materials. For a deeper quantitative dive, see the BBWI analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 699.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 6.06 > 1.0 |
| NWC/Revenue: 4.46% < 20% (prev 1.95%; Δ 2.51% < -1%) |
| CFO/TA 0.24 > 3% & CFO 1.18b > Net Income 699.0m |
| Net Debt (4.74b) to EBITDA (1.50b): 3.16 < 3 |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (211.6m) vs 12m ago -3.37% < -2% |
| Gross Margin: 44.13% > 18% (prev 0.44%; Δ 4369 % > 0.5%) |
| Asset Turnover: 147.5% > 50% (prev 149.1%; Δ -1.64% > 0%) |
| Interest Coverage Ratio: 4.38 > 6 (EBITDA TTM 1.50b / Interest Expense TTM 283.0m) |
Altman Z'' 0.70
| A: 0.07 (Total Current Assets 1.88b - Total Current Liabilities 1.55b) / Total Assets 4.99b |
| B: -0.35 (Retained Earnings -1.75b / Total Assets 4.99b) |
| C: 0.25 (EBIT TTM 1.24b / Avg Total Assets 4.99b) |
| D: -0.24 (Book Value of Equity -1.57b / Total Liabilities 6.58b) |
| Altman-Z'' Score: 0.70 = B |
Beneish M -3.30
| DSRI: 0.85 (Receivables 169.0m/200.0m, Revenue 7.35b/7.43b) |
| GMI: 1.00 (GM 44.13% / 43.97%) |
| AQI: 0.93 (AQ_t 0.20 / AQ_t-1 0.22) |
| SGI: 0.99 (Revenue 7.35b / 7.43b) |
| TATA: -0.10 (NI 699.0m - CFO 1.18b) / TA 4.99b) |
| Beneish M-Score: -3.30 (Cap -4..+1) = AA |
What is the price of BBWI shares?
Over the past week, the price has changed by +5.73%, over one month by +4.58%, over three months by +3.02% and over the past year by -36.50%.
Is BBWI a buy, sell or hold?
- StrongBuy: 7
- Buy: 4
- Hold: 8
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the BBWI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 24.6 | 6.8% |
| Analysts Target Price | 24.6 | 6.8% |
| ValueRay Target Price | 20.9 | -9.4% |
BBWI Fundamental Data Overview February 04, 2026
P/E Forward = 6.6445
P/S = 0.6236
P/EG = 1.1077
Revenue TTM = 7.35b USD
EBIT TTM = 1.24b USD
EBITDA TTM = 1.50b USD
Long Term Debt = 3.89b USD (from longTermDebt, last quarter)
Short Term Debt = 193.0m USD (from shortTermDebt, last quarter)
Debt = 4.98b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.74b USD (from netDebt column, last quarter)
Enterprise Value = 9.33b USD (4.59b + Debt 4.98b - CCE 236.0m)
Interest Coverage Ratio = 4.38 (Ebit TTM 1.24b / Interest Expense TTM 283.0m)
EV/FCF = 9.86x (Enterprise Value 9.33b / FCF TTM 946.0m)
FCF Yield = 10.14% (FCF TTM 946.0m / Enterprise Value 9.33b)
FCF Margin = 12.86% (FCF TTM 946.0m / Revenue TTM 7.35b)
Net Margin = 9.51% (Net Income TTM 699.0m / Revenue TTM 7.35b)
Gross Margin = 44.13% ((Revenue TTM 7.35b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 41.32%)
Tobins Q-Ratio = 1.87 (Enterprise Value 9.33b / Total Assets 4.99b)
Interest Expense / Debt = 1.37% (Interest Expense 68.0m / Debt 4.98b)
Taxrate = 25.24% (26.0m / 103.0m)
NOPAT = 926.2m (EBIT 1.24b * (1 - 25.24%))
Current Ratio = 1.21 (Total Current Assets 1.88b / Total Current Liabilities 1.55b)
Debt / Equity = -3.13 (negative equity) (Debt 4.98b / totalStockholderEquity, last quarter -1.59b)
Debt / EBITDA = 3.16 (Net Debt 4.74b / EBITDA 1.50b)
Debt / FCF = 5.01 (Net Debt 4.74b / FCF TTM 946.0m)
Total Stockholder Equity = -1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.02% (Net Income 699.0m / Total Assets 4.99b)
RoE = -46.79% (negative equity) (Net Income TTM 699.0m / Total Stockholder Equity -1.49b)
RoCE = 51.71% (EBIT 1.24b / Capital Employed (Equity -1.49b + L.T.Debt 3.89b))
RoIC = 38.71% (NOPAT 926.2m / Invested Capital 2.39b)
WACC = 6.26% (E(4.59b)/V(9.57b) * Re(11.96%) + D(4.98b)/V(9.57b) * Rd(1.37%) * (1-Tc(0.25)))
Discount Rate = 11.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.66%
[DCF Debug] Terminal Value 84.25% ; FCFF base≈824.8m ; Y1≈783.2m ; Y5≈747.9m
Fair Price DCF = 74.68 (EV 20.03b - Net Debt 4.74b = Equity 15.29b / Shares 204.7m; r=6.26% [WACC]; 5y FCF grow -6.55% → 2.90% )
EPS Correlation: -27.55 | EPS CAGR: -39.47% | SUE: -0.70 | # QB: 0
Revenue Correlation: -20.31 | Revenue CAGR: -15.73% | SUE: -1.32 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.28 | Chg30d=-0.047 | Revisions Net=-1 | Analysts=13
EPS next Year (2027-01-31): EPS=2.58 | Chg30d=-0.131 | Revisions Net=-1 | Growth EPS=-12.1% | Growth Revenue=-2.3%